Concepedia

Hege Marie Vedeld

HM

12

Publications

661

Citations

11

H-Index

2012

Active since

Affiliations

Oslo University Hospital(Current)

University of Oslo

Norwegian Cancer Society

Imperial College London

Institute of Biomedical Science

Hege Marie Vedeld is an author at Oslo University Hospital specializing in pathology, medicine, and cancer research.

Top concepts

Publications per year

2012–2023

12

Publications

12

The novel colorectal cancer biomarkers <i>CDO1, ZSCAN18</i> and <i>ZNF331</i> are frequently methylated across gastrointestinal cancers

Hege Marie Vedeld, Kim Andresen, Ina A. Eilertsen et al. · International Journal of Cancer · 2014 · 118 citations · Full text

, , +18

Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma

Kim Andresen, Kirsten Muri Boberg, Hege Marie Vedeld et al. · Hepatology · 2015 · 108 citations · Full text

Novel target genes and a valid biomarker panel identified for cholangiocarcinoma

Kim Andresen, Kirsten Muri Boberg, Hege Marie Vedeld et al. · Epigenetics · 2012 · 78 citations · Full text

, , +20

Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer

Hege Marie Vedeld, Arild Nesbakken, Ragnhild A. Lothe et al. · Clinical Epigenetics · 2018 · 71 citations · Full text

The recently suggested intestinal cancer stem cell marker<i>DCLK1</i>is an epigenetic biomarker for colorectal cancer

Hege Marie Vedeld, Rolf I. Skotheim, Ragnhild A. Lothe et al. · Epigenetics · 2014 · 58 citations · Full text

, , +16

Rows per page

1–5 of 12